Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Do immune checkpoint inhibitors work in EGFR mutant lung cancer?
Dr Edward Garon - UCLA Medical Center, Santa Monica, USA
Do immune checkpoint inhibitors work in EGFR mutant lung cancer? ( Dr Edward Garon - UCLA Medical Center, Santa Monica, USA )
22 May 2020
COVID-19: Risk of millions relapsing back to smoking
Dr Sudhanshu Patwardhan - Centre for Health Research and Education, Southampton,...
COVID-19: Risk of millions relapsing back to smoking ( Dr Sudhanshu Patwardhan - Centre for Health Research and Education, Southampton, UK )
22 May 2020
TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patie...
Dr Heather Wakelee - Stanford University Medical Center, Stanford, USA
TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patients with COVID-19 ( Dr Heather Wakelee - Stanford University Medical Center, Stanford, USA )
21 May 2020
COVID-19: Management of non-small cell lung cancer patients during the coronavir...
Dr Heather Wakelee - Stanford University, Stanford, USA
COVID-19: Management of non-small cell lung cancer patients during the coronavirus pandemic ( Dr Heather Wakelee - Stanford University, Stanford, USA )
12 May 2020
Prostate cancer patients receiving androgen-deprivation therapies shown to be at...
Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerla...
Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19 ( Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerland )
7 May 2020
COVID-19: The situation in Florida and managing lung cancer patients
Dr. Luis Raez - Memorial Healthcare System, Florida, Miami
COVID-19: The situation in Florida and managing lung cancer patients ( Dr. Luis Raez - Memorial Healthcare System, Florida, Miami )
27 Apr 2020
New oncogenic drivers in NSCLC
Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands
New oncogenic drivers in NSCLC ( Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands )
23 Apr 2020
The potential of KRAS inhibitors for non-small-cell lung cancer
Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany
The potential of KRAS inhibitors for non-small-cell lung cancer ( Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany )
22 Apr 2020
COVID-19: The management of coronavirus patients with cancer, examples from Ital...
Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy
COVID-19: The management of coronavirus patients with cancer, examples from Italy ( Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy )
31 Mar 2020
Management of mutation-negative NSCLC
Dr Vijay Patil - Tata Medical Center, Kolkata, India
Management of mutation-negative NSCLC ( Dr Vijay Patil - Tata Medical Center, Kolkata, India )
6 Mar 2020
Systematic therapy of driver mutated NSCLC
Dr Vijay Patil - Tata Medical Center, Kolkata, India
Systematic therapy of driver mutated NSCLC ( Dr Vijay Patil - Tata Medical Center, Kolkata, India )
6 Mar 2020
Loco-regionally advanced NSCLC: Radiation oncologist's perspective
Prof Simon Pavamani - Christian Medical College, Vellore, India
Loco-regionally advanced NSCLC: Radiation oncologist's perspective ( Prof Simon Pavamani - Christian Medical College, Vellore, India )
6 Mar 2020